SCHEMBL25599094

SCHEMBL25599094

Cn1c(N2CCCC(O)C2)nc2cc([N+](=O)[O-])ccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
PKM P14618 2/20 0.52
LMNA P02545 6/20 0.51
KMT2A Q03164 4/20 0.51
MEN1 O00255 2/20 0.51
CYP2D6 P10635 1/20 0.51
RHOA P61586 1/20 0.45
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
POLB P06746 1/20 0.44
APOBEC3A P31941 2/20 0.41
APOBEC3G Q9HC16 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HIF1A Q16665 1/20 0.41
MAPK1 P28482 1/20 0.41
PIK3CD O00329 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25673301 0.87 ALDH1A1 (0.53) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL30533920 0.86 ALDH1A1 (0.52) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL25220131 0.86 ALDH1A1 (0.52) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL25268541 0.86 ALDH1A1 (0.52) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL25598188 0.84 ALDH1A1 (0.66) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL25269747 0.83 PKM (0.48) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL25269748 0.83 PKM (0.48) ALDH1A1PKMLMNAKMT2AMEN1
SCHEMBL25599182 0.81 LMNA (0.45) ALDH1A1LMNAKMT2AMEN1MAPT
SCHEMBL25599061 0.80 NPC1 (0.40) ALDH1A1KMT2AMEN1MAPTSMN1; SMN2
SCHEMBL25680779 0.80 NPC1 (0.40) ALDH1A1KMT2AMEN1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023102184-A1 BICYCLIC AMINE COMPOUNDS AS CDK12 INHIBITORS INCYTE CORPORATION (US) 2023-06-08 WO disclosed